Aquinox Pharmaceuticals, Inc.

  • Date: 2016-01-26

Download Original Document

NOTICE DECLARING INTENTION TO BE QUALIFIED UNDER NATIONAL INSTRUMENT 44-101 SHORT FORM PROSPECTUS DISTRIBUTIONS (“NI 44-101”) December 22, 2015 To: British Columba Securities Commission Aquinox Pharmaceuticals, Inc. (the “Issuer”) intends to be qualified to file a short form prospectus under NI 44-101. The Issuer acknowledges that it must satisfy all applicable qualification criteria prior to filing a preliminary short form prospectus. This notice does not evidence the Issuer’s intent to file a short form prospectus, to enter into any particular financing or transaction or to become a reporting issuer in any jurisdiction. This notice will remain in effect until withdrawn by the Issuer.

AQUINOX PHARMACEUTICALS, INC.

By: “Kamran Alam” Name: Kamran Alam Title: Vice President, Finance and Chief Financial Officer

MT DOCS 15127601v1